ystematic review on the clinical management of chronic pain and comorbid opioid use disorder
DOI:
https://doi.org/10.20882/adicciones.1680Keywords:
opioid use disorder, chronic pain, methadone, buprenorphine, cognitive behavioral therapyAbstract
The crisis caused by prescribed opioids and their related side effects are a public health problem worldwide. Most of these are prescribed for coping with chronic pain. The coexistence of opioid use disorder (OUD) in patients with chronic pain represents a complex challenge due to the need for managing both pain and OUD. The aim of this systematic review is to evaluate the efficacy of feasible treatments for this population with OUD and comorbid chronic pain for both conditions. A systematic database search has been performed using Cochrane Library, MEDLINE, PsycINFO and ClinicalTrials.gov in compliance with PRISMA guidelines. Eligible articles addressed the outcomes in chronic pain patients with comorbid opioid use disorder after treatment interventions were applied. Of 593 identified articles, nine were eligible for qualitative review (n = 7 pharmacological interventions; n = 2 psychological interventions). Methadone, buprenorphine, cognitive-behavioral and mindfulness showed promising results, but data were inconclusive (<2 RCT with low risk of bias). It is unclear whether the opioid agonist treatment should be maintained or tapered and which drug should be prescribed for the opioid substitution therapy (methadone or buprenorphine/naloxone). Mindfulness and cognitive behavioral therapy have a discrete effect on improving negative affect but not pain. The therapeutic approach might be individualized under a shared decision-making basis.References
American Psychiatric Association. (1993). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). American Psychiatric Association.
American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders (4th-TR ed.). American Psychiatric Association.
Barry, D. T., Beitel, M., Cutter, C. J., Fiellin, D. A., Kerns, R. D., Moore, B. A.,… Schottenfeld, R. S. (2019). An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain. Drug and Alcohol Dependence, 194, 460–467. doi:10.1016/j.drugalcdep.2018.10.015.
Beck, A., Ward, C., Mendelson, M., Mock, J. y Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571. doi:10.1001/archpsyc.1961.01710120031004.
Blondell, R. D., Ashrafioun, L., Dambra, C. M., Foschio, E. M., Zielinski, A. L. y Salcedo, D. M. (2010). A clinical trial comparing tapering doses of buprenorphine with steady doses for chronic pain and co-existent opioid addiction. Journal of Addiction Medicine, 4, 140–146. doi:10.1097/ADM.0b013e3181ba895d.
Bowen, S., Chawla, N. y Marlatt, G. A. (2011). Mindfulness-based relapse prevention for addictive behaviors: A clinician’s guide. Guilford Press.
Brown, R. E. y Sloan, P. A. (2017). The opioid crisis in the United States. Anesthesia & Analgesia, 125, 1432–1434. doi:10.1213/ANE.0000000000002417.
Busse, J. W., Craigie, S., Juurlink, D. N., Buckley, D. N., Li, W., Couban, R. J.,… Guyatt, G.B H. (2017). Guideline for opioid therapy and chronic noncancer pain. Cmaj, 189, 659–666. doi:10.1503/cmaj.170363.
Butner, J. L., Bone, C., Ponce Martinez, C. C., Kwon, G., Beitel, M., Madden, L. M.,… Barry, D. T. (2018). Training addiction counselors to deliver a brief psychoeducational intervention for chronic pain among patients in opioid agonist treatment: A pilot investigation. Substance Abuse, 39, 199–205. doi:10.1080/08897077.2018.1449052.
Chen, J. Y., Yu, J. C., Cao, J. P., Xiao, Y., Gu, H., Zhong, R. l.,… Wang, Z. Z. (2019). Abstinence following a motivation-skill-desensitization-mental energy intervention for heroin dependence: A three-year follow-up result of a randomized controlled trial. Current Medical Science, 39, 472–482. doi:10.1007/s11596-019-2062-y.
Chou, R., Turner, J. A., Devine, E. B., Hansen, R. N., Sullivan, S. D., Blazina, I.,… Deyo, R. A. (2015). The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a national institutes of health pathways to prevention workshop. Annals of Internal Medicine, 162, 276–286. doi:10.7326/M14-2559.
Cleeland, C. S. (2009). The brief pain inventory user guide. Recuperado de https://www.mdanderson.org/documents/Departments-and-Divisions/Symptom-Research/BPI_UserGuide.pdf.
Dowell, D., Haegerich, T. y Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain—United States. JAMA, 315, 1624–1645.
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B. y Otto, M. W. (2008). A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry, 165, 179–187. doi:10.1176/appi.ajp.2007.06111851.
Eccleston, C., Fisher, E., Thomas, K. H., Hearn, L., Derry, S., Stannard, C.,… Moore, R. A. (2017). Interventions for the reduction of prescribed opioid use in chronic non-cancer pain. Cochrane Database of Systematic Reviews, 41, 329–330. doi:10.1002/14651858.CD010323.pub3.
Eilender, P., Ketchen, B., Maremmani, I., Saenger, M. y Fareed, A. (2016). Treatment approaches for patients with opioid use disorder and chronic noncancer pain: A literature review. Addictive Disorders & Their Treatment, 15, 85–98. doi:10.1097/ADT.0000000000000078.
Els, C., Straube, S., Jackson, T., Kunyk, D., Lappi, V., Sonnenberg, B.,… Kolahdooz, F. (2017). Adverse events associated with medium-and long-term use of opioids for chronic non-cancer pain: An overview of cochrane reviews (review). Adverse events associated with medium-and long-term use of opioids for chronic. Cochrane Database of Systematic Reviews, 10. doi:10.1002/14651858.CD012509.pub2.
Garland, E. L., Hanley, A. W., Kline, A. y Cooperman, N. A. (2019). Mindfulness-oriented recovery enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial. Drug and Alcohol Dependence, 203, 61-65. doi:10.1016/j.drugalcdep.2019.07.007.
Garland, E. L. y Howard, M. O. (2013). Mindfulness-oriented recovery enhancement reduces pain attentional bias in chronic pain patients. Psychotherapy and Psychosomatics, 82, 311-318. doi:10.1159/000348868.
Garland, E. L. y Howard, M. O. (2018). Mindfulness-based treatment of addiction: Current state of the field and envisioning the next wave of research. En Addiction Science and Clinical Practice (Vol. 13, Issue 1). BioMed Central Ltd. doi:10.1186/s13722-018-0115-3.
Garland, E. L., Manusov, E. G., Froeliger, B., Kelly, A., Williams, J. M. y Howard, M. O. (2014). Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: Results from an early-stage randomized controlled trial. Journal of Consulting and Clinical Psychology, 82, 448–459. doi:10.1037/a0035798.
Gracely, R. H. y Kwilosz, D. M. (1988). The Descriptor Differential Scale: Applying psychophysical principles to clinical pain assessment. Pain, 35, 279–288. doi:10.1016/0304-3959(88)90138-8.
Heinzerling, K. G. (2019). Applying best practice guidelines on chronic pain in clinical practice. Treating patients who suffer from pain and addiction. En I. Danovitch & L. J. Mooney (Eds.), The assessment and treatment of addiction: Best practices and new frontiers (pp. 137–156). Missouri: Elsevier.
Ilgen, M. A., Bohnert, A. S. B., Chermack, S., Conran, C., Jannausch, M., Trafton, J. y Blow, F. C. (2016). A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction, 111, 1385–1393. doi:10.1111/add.13349.
International Association for the Study of Pain. (2020). IASP Announces Revised Definition of Pain. Pain. Recuperado de https://www.iasp-pain.org/PublicationsNews/NewsDetail.aspx?ItemNumber=10475.
Kampman, K. y Jarvis, M. (2015). American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. Journal of Addiction Medicine, 9, 358–367. doi:10.1097/ADM.0000000000000166.
Knisely, J. S., Wunsch, M. J., Cropsey, K. L. y Campbell, E. D. (2008). Prescription opioid misuse index: A brief questionnaire to assess misuse. Journal of Substance Abuse Treatment, 35, 380–386. doi:10.1016/j.jsat.2008.02.001.
Li, W., Howard, M. O., Garland, E. L., McGovern, P. y Lazar, M. (2017). Mindfulness treatment for substance misuse: A systematic review and meta-analysis. Journal of Substance Abuse Treatment, 75, 62–96. doi:10.1016/j.jsat.2017.01.008.
Mattick, R. P., Breen, C., Kimber, J. y Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, CD002207. doi:10.1002/14651858.CD002207.pub4.
Moher, D., Liberati, A., Tetzlaff, J. y Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ, 339, 2535–2535. doi:10.1136/bmj.b2535.
Morasco, B. J., Gritzner, S., Lewis, L., Oldham, R., Turk, D. C. y Dobscha, S. K. (2011). Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain, 152, 488–497. doi:10.1016/j.pain.2010.10.009.
Murdoch University. (2021). Systematic Reviews - Research Guide. Library. Recuperado de https://libguides.murdoch.edu.au/systematic/databases.
Nahin, R. L. (2015). Estimates of pain prevalence and severity in adults: United States, 2012. The Journal of Pain, 16, 769–780. doi:10.1016/j.jpain.2015.05.002.
National Institutes of Health. (2014). Pathways to prevention workshop: The role of opioids in the treatment of chronic pain (Vol. 1). doi: 10.1017/CBO9781107415324.004.
National Library of Medicine US. (2019). Buprenorphine and methadone for opioid-dependent chronic back pain patients. Recuperado de https://clinicaltrials.gov/ct2/show/NCT01559454?cond=buprenorphine+methadone+low+back+pain&draw=2&rank=1.
Neumann, A. M., Blondell, R. D., Hoopsick, R. A. y Homish, G. G. (2019). Randomized clinical trial comparing buprenorphine/naloxone and methadone for the treatment of patients with failed back surgery syndrome and opioid addiction. Journal of Addictive Diseases, 0, 1–9. doi:10.1080/10550887.2019.1690929.
Neumann, A. M., Blondell, R. D., Jaanimägi, U., Giambrone, A. K., Homish, G. G., Lozano, J. R.,… Azadfard, M. (2013). A preliminary study comparing methadone and buprenorphine in patients with chronic pain and co-existent opioid addiction. Journal of Addictive Diseases, 32, 68–78. doi:10.1080/10550887.2012.759872.
Noble, M., Treadwell, J. R., Tregear, S. J., Coates, V. H., Wiffen, P. J., Akafomo, C. y Schoelles, K. M. (2010). Long-term opioid management for chronic noncancer pain. Cochrane Database of Systematic Reviews, 3. doi:10.1002/14651858.CD006605.
Pade, P. A., Cardon, K. E., Hoffman, R. M. y Geppert, C. M. A. (2012). Prescription opioid abuse, chronic pain, and primary care: A co-occurring disorders clinic in the chronic disease model. Journal of Substance Abuse Treatment, 43, 446–450. doi:10.1016/j.jsat.2012.08.010.
Rhodin, A., Grönbladh, L., Nilsson, L.-H. y Gordh, T. (2006). Methadone treatment of chronic non-malignant pain and opioid dependence- a long-term follow-up. European Journal of Pain, 10, 271–278. doi:10.1016/j.ejpain.2005.05.003.
Rudd, R. A., Seth, P., David, F. y Scholl, L. (2016). Increases in drug and opioid-involved overdose deaths — United States, 2010–2015. MMWR. Morbidity and Mortality Weekly Report, 65, 1445–1452. doi:10.15585/mmwr.mm655051e1.
Skinner, H. A. (1982). The Drug Abuse Screening Test (DAST). Addictive Behaviors, 7, 1.
Sterne, J. A. C., Savovi ´c, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I.,… Higgins, J. P. T. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ, 366. doi:10.1136/bmj.l4898.
Streltzer, J., Davidson, R. y Goebert, D. (2015). An observational study of buprenorphine treatment of the prescription opioid dependent pain patient. The American Journal on Addictions, 24, 357–361. doi:10.1111/ajad.12198.
Sullivan, M. D., Turner, J. A., DiLodovico, C., D’Appollonio, A., Stephens, K. y Chan, Y.-F. (2017). Prescription opioid taper support for outpatients with chronic pain: A randomized controlled trial. The Journal of Pain, 18, 308–318. doi:10.1016/j.jpain.2016.11.003.
Vidrine, J. I., Spears, C. A., Heppner, W. L., Reitzel, L. R., Marcus, M. T., Cinciripini, P. M.,… Wetter, D. W. (2016). Efficacy of mindfulness-based addiction treatment (MBAT) for smoking cessation and lapse recovery: A randomized clinical trial. Journal of Consulting and Clinical Psychology, 84, 824–838. doi: 10.1037/ccp0000117.
Volkow, N. D. y Thomas McLellan, A. (2016). Opioid abuse in chronic pain-misconceptions and mitigation strategies. New England Journal of Medicine, 374, 1253–1263. doi:10.1056/NEJMra1507771.
Vowles, K. E., McEntee, M. L., Julnes, P. S., Frohe, T., Ney, J. P. y Van Der Goes, D. N. (2015). Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis. Pain, 156, 569–576. doi:10.1097/01.j.pain.0000460357.01998.f1.
Waddell, G., McCulloch, J. y Kummel, E. (1980). Nonorganic physical signs in low back pain. Spine, 5, 117–125.
Weiss, R. D., Sharpe Potter, J., Fiellin, D. A., Byrne, M., Connery, H. S., Dickinson, W.,… Ling, W. (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Arch Gen Psychiatry, 68, 1238–1246.
Wiffen, P. J., Wee, B., Derry, S., Bell, R. F. y Moore, R. A. (2017). Opioids for cancer pain - an overview of cochrane reviews. Cochrane Database of Systematic Reviews, 2017. doi:10.1002/14651858.CD012592.pub2.
Williams, A. C. de C., Eccleston, C. y Morley, S. (2012). Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database of Systematic Reviews, 11. doi:10.1002/14651858.CD007407.pub3.
Organización Mundial de la Salud. (2019). Chronic pain. International Classification of Diseases - 11th Edition. Recuperado de https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1581976053.
Worley, M. J., Heinzerling, K. G., Shoptaw, S. y Ling, W. (2017). Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction. Addiction, 112, 1202–1209. doi:10.1111/add.13782.
